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Abstract
Background: Epidemiological estimates for lifetime cumulative incidence indicate
that for every 9-11 who start using cannabis, one becomes a case of the cannabis
dependence syndrome (CDS) – i.e., roughly 9%-11%. More recent estimates clarify
that CDS risk might be much lower among ’cannabis only’ users, due in part to
the fact that many ’cannabis only’ users try the drug a few times and never again.
We turned to Hill functional analysis in order to study CDS probability soon after
1st cannabis use, estimated across strata defined by the number of recent days of
cannabis use, with an acknowledgment that a persistence of cannabis use beyond
a few trials (may signify a potentially higher risk subgroup).
Methods: United States National Surveys on Drug Use and Health (NSDUH),
2004-2014, sampled and assessed more than 500,000 participants, yielding a na-
tionally representative probability sample of 13,874 newly incident cannabis users,
with CDS assessment no more than 12 months since 1st use. For this analysis, we
focused on the subgroup of 4,934 subjects with persistence of cannabis use into the
30 days prior to assessment. For this subgroup, we used Hill functions to estimate
variations in CDS probability across strata defined by cannabis-using days during
the 30 days prior to assessment, and by history of using other psychoactive drug
compounds.
Results: Our preliminary results show that among ’cannabis only’ users (n=1,811)
the probability of CDS starts at about 1% for occasional users (95% bootstrap con-
fidence interval, CI: 0, 2), rising to about 9% for daily users (95% CI: 4.5, 23).
However, estimated probability of CDS for daily users is greater when cannabis
plus ethanol (but no other drugs) is being used (n=1,753): 63% (95% CI: 47, 84);
here, use on same day is not required. Our presentation will show additional Hill
function estimates for other cannabis and drug combinations (e.g., cannabis and
tobacco, cannabis and alcohol and tobacco).
Conclusions Notwithstanding NSDUH self-report methods and other limitations,
the main finding is that probability of observing cannabis dependence is greater
when cannabis use co-occurs with other psychoactive drug use. CDS probability is
relatively low for ’cannabis only’ users even when ’trial’ users are excluded. These
epidemiological estimates are consistent with a re-appraisal of cannabis dependence
risk for ’cannabis only’ users.
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Figure 1:The four parameters – Pmn, Pm, PD50 and k, –
determine the shape of a Hill curve.
The increasing relationship
can be explicitly described by
the four parameters of a Hill
function:
y = ƒ () =
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
PD50

k + Pmn.
Pm = upper limit
Pmn = lower limit
k = slope at the inflection point
PD50 = effective dose 50, i.e., a
value of x, for which the value of y is
half way between Pm and Pmn
A non-linear approach via a parametric function provides a straightforward and
meaningful four-parameter interpretation.
More typical epidemiological approaches (e.g., the logistic regression) do not pro-
vide the four-parameter estimation quantities used to compare drug combinations.
Results: Variation in Probability of CDS Soon After 1st Cannabis Use
Materials
In aggregate, the National Surveys of Drug Use and Health (NSDUH),
2004-2014, identified 13,874 newly incident cannabis users (<12 months
since 1st use). Among them, 4,943 continued use to within 30 days of
assessment. Further, concurrent drug combinations with cannabis were:
tobacco cigarettes only (TCIG; n = 554), alcohol only (AONLY),
n = 1,753), alcohol & tobacco cigarettes (ALCCIG, n = 1,391)
Table 1∗Parameters (95% Bootstrap Confidence Intervals)
Pmn Pm PD50 k
CAN ONLY 1.1% (0.0, 2.4%) 9.0% (4.5, 23.9%) 5 days (3, 29) 20 (1, 100)
CAN + CIG 3.0% (0.9, 4.5%) 12.9% (6.3, 18.8%) 13 days (12, 16) 100 (7, 100)
CAN + ALC 1.8% (0.0, 4.1%) 63.3% (47.1, 84.7%) 12 days (11, 13) 100 (13, 100)
CAN + CIG + ALC 4.8% (2.6, 6.4%) 38.1% (24.9, 49.3%) 20 days (19, 23) 100 (16, 100)
∗Comparative estimates of Hill function parameters characterizing probability of observing CDS soon after first occurrence of newly incident
cannabis use. Data from the United States National Surveys on Drug Use and Health, 2004-2014.
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Figure 2:Estimated non-linear Hill functions for the predicted probability of cannabis dependence syndrome observed among newly incident cannabis users within 12 months after 1st use.
Main Findings
Figure 1 presents the estimated Hill function curves with the shaded re-
gions depicting 95% bootstrap confidence intervals (CI). Based on the
Hill function parameter estimates, CDS is observed among about 9% of
the daily cannabis users with no co-occurring use of alcohol or tobacco
cigarettes, with a much lower CDS estimate for infrequent ’cannabis
only’ users (∼ 2%). Figure 1 also suggests that the co-use of tobacco
cigarettes (without alcohol) does not signal increased probability of ob-
serving CDS soon after 1st cannabis use, while co-occurring use of al-
cohol is linked to greater CDS probability among daily cannabis users
(∼63%; 95% CI = 47%, 85%). Newly incident cannabis users with
recent co-occurring cannabis, tobacco cigarette, and alcohol use are
also much more likely to be observed with cannabis dependence ver-
sus cannabis only users. Note that in Table 1, estimated PD50 for
CAN+CIG+ALC is 20 days (95% CI = 19, 23) versus 12-13 days for
other combinations and just 5 days for ‘cannabis only’ users.
Limitations
Of special concern is the self-report interview survey data from NSDUH. However, in the
context of nationally representative sample surveys on this scale, there are few logistically
feasible and affordable alternatives to self-report. In addition, cross-sectional data always
will be inferior to longitudinal data when fitting Hill functions of this type. Nonetheless, in
these cross-sectional estimates, we can forecast what a followup study might show about
variation in probability of developing cannabis dependence within 12 months after 1st
cannabis use, with relatively smaller estimates for ‘cannabis only’ users and substantially
larger estimates for ‘polydrug’ newly onset users. Finally, feedback loops might be present
(Anthony, 2010) such that cannabis dependence, once it develops, may have prompted
infrequent users to become daily users. This possibility is moving our work in the direction
of restrictions on the Hill function and other future improvements of our functional
analysis approaches to estimation of drug dependence risk.
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